ZVSA

ZyVersa Therapeutics, Inc.

Healthcare · Biotechnology

$364.46 sample

+3.53 (+0.98%) 1D

Market cap

$530.6B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-23

Alerts

8

Price$364.46 +25.30% 3M daily closessample

364.46290.12

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider buy: Director
Sep 23SECForm 144 filed
Sep 16SEC10-Q filed
Sep 10SEC10-Q filed
Sep 04INSInsider sell: General Counsel
Aug 31SECDEF 14A filed
Aug 20INSInsider buy: Director
Aug 13SEC10-Q filed

Sign up to see the real ZVSA record →

Company facts

SEC EDGAR registration

Name: ZyVersa Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -52sample, -100 to +100
Reporting currency: USD

Who is positioning in ZVSA

sample

Insiders: 33 insider transactions over 90 days, net selling, $599.5M
Congress: No member trades over 90 days
Institutions · 13F: 33 funds hold $10.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$30.7B +13.4% y/y

Q4 2024Q3 2026

Inventory$18.0B +9.1% y/y

Q4 2024Q3 2026

Accounts receivable$14.1B +15.2% y/y

Q4 2024Q3 2026

Total debt$35.9B +2.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $55.0B +1.0% 3M
Sample peer B: $140.3B -9.0% 3M
Sample peer C: $510.9B -7.4% 3M
Sample peer D: $89.8B +14.7% 3M
Sample peer E: $112.5B +1.8% 3M